The pioneer study of Zhang et al. further revealed that Kras-driven oncogenesis of pancreatic cancer established an immunosuppressive microenvironment via recruitment and activity of CD4+ T lymphocytes (53). This evidence concerns the gene KRAS and familial pancreatic carcinoma.